4D-QSAR Analysis of a Set of Ecdysteroids and a Comparison to CoMFA Modeling

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 6, 2001, Pages 1587-1604

  Ravi, Malini ^a   Hopfinger, Anton J ^a   Hormann, Robert E ^b   Dinan, Laurence ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RHeoGene   (United States)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ECDYSTEROID;

ANIMAL; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DROSOPHILA MELANOGASTER; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMAL; CELL LINE; COMPARATIVE STUDY; DROSOPHILA MELANOGASTER; ECDYSTEROIDS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T;

CELLS; CONFORMATIONS; HYDROGEN BONDS; HYDROPHOBICITY; MATHEMATICAL MODELS; MOLECULES;

ECDYSTEROIDS;

GENES;

EID: 0035498341     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010076u     Document Type: Article

References (63)

1. Gomez-Navarro, J.; Curiel, D. T.; Douglas, J. T. Gene therapy for cancer. Eur. J. Cancer 1999, 35, 2039-2057.
2. Costantini, L. C.; Bakowska, J. C.; Breakefield, X. O.; Isacson, O. Gene therapy in the CNS. Gene Ther. 2000, 7, 93-109.
3. Yla-Herttuala, S.; Martin, J. F. Cardiovascular gene therapy. Lancet 2000, 335, 213-222.
4. Flotte, T. R. Gene therapy for cystic fibrosis. Curr. Opin. Mol. Ther. 1999, 1, 510-518.
5. Tsokos, G. C.; Nepom, G. T. Gene therapy in the treatment of autoimmune diseases. J. Clin. Invest. 2000, 106, 181-183.
6. Mountain, A. A. Gene therapy: the first decade. Trends Biotechnol. 2000. 18, 119-128.
7. French Anderson, W. Human gone therapy. Nature 1998, 392 (6679, supp.), 25-30.
8. Bestor, T. H. Gene silencing as a threat to the success of gene therapy. J. Clin. Invest. 2000, 105, 409-411.
9. Pouton, C. W. Biological harriers to gene transfer. Drug Targetting Delivery 1999, 10, 65-102.
10. Zuo, J.; Chua, N.-H. Chemical-inducible systems for regulated expression of plant genes. Curr. Op. Biotech. 2000, 11, 146-151.
11. Agha-Mohammadi, S.; Loize, M. T. Regulatable systems: applications in gene therapy and replicating viruses. J. Clin. Invest. 2000, 105, 1177-1183.
12. Clackson, T. Regulated gene expression systems, Gene Therapy, 2000, 7, 120-125.
13. Allgood, V. E.; Eastman, E. M. Chimeric receptors as gene switches, Curr. Opin. Biotechnol. 1997, 8, 474-479.
14. Lezzi, M.; Bergman, T.; Mouillet, J.-F.; Henrich, V. C. The ecdysone receptor puzzle. Arch. Insect Biochem. Physoil. 1999, 41, 99-106.
15. Yao, T.-P.; Forman, B. M.; Jiang, Z.; Cherbas, L.; Chen, J.-D.; McKeown, M.; Cherbas, P.; Evans, R. M. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes, Nature 1993, 366, 476- 479.
16. Kumar, R.; Thompson, E. B. The structure of the nuclear hormone receptors, Steroids 1999, 64, 310-319.
17. Moras, D.; Gronemeyer, H. The nuclear receptor ligand binding domain: structure and function. Curr. Opin. Cell Biol. 1998, 10, 384- 391.
18. Weatherman, R. V.; Fletterick, R. J.; Scanlan, T. S. Nuclear-Receptor ligands and ligand-binding domains. Annu. Rev. Biochem. 1999, 68, 559-581.
19. No, D.; Yao, T.-P.; Evans, R. M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 3346-3351.
20. Luers, G. H.; Jess, N.; Franz, T. Reporter-linked monitoring of transgene expression in living cells using the ecdysone-inducible promoter system. Eur. J. Cell Biol. 2000, 79, 653-657.
21. Gingrich, J. R.; Roder, J. Inducible gene expression in the nervous system of transgenic mice, Annu. Rev. Neurosci. 1998, 21, 377-405.
22. Saez, E.; Nelson, M. C.; Eshclman, B.; Banayo, E.; Koder, A.; Cho, G. J.; Evans, R. M. Identification of ligands and coligands for the ecdysone-regulated gene switch, Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 14512-14517.
23. Pastorino, J. G.; Chen, S. T.; Tufani, M.; Snyder, J. W.; Farber, J. L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 1998, 273, 7770- 7775.
24. 50 values for ponasterone A and muristerone A, several of the more active ccdysteroids in gene-switch assays, are generally 10- 1000x higher in mammalian cells than in Drosophila cells.
25. Dinan, L.; Hormann, R. E.; Fujimoto, T. An extensive ecdysteroid CoMFA. J. Comput.-Aided Mol. Des. 1999, 13, 185-207.
26. McDonnell, D. P.; Vegeto, E.; Gleeson, M. A. G. Nuclear hormone receptors as targets for new drug discovery. Bio/Technology 1993, 11, 1256-1261.
27. Rosen, J.; Day, A.; Jones, T. K.; Jones, E. T. T.; Nadzan, A. M.; Stein, R. B. Intracellular receptors and signal transducers and activators of transcription superfamilies: novel targets for small-molecule drug discovery. J. Med. Chem. 1995, 38, 4855-4874.
28. Dinan, L.; Savchenko, T.; Whiting, P.; Sarker, S. D. Plant natural products as insect steroid receptor agonists and antagonists. Pesticide Sci. 1999, 55, 331-335.
29. Wing, K. D. RH 5849, a nonsteroidal ecdysone agonist: effects on a Drosophila cell line. Science 1988, 241, 467-469.
30. Wing, K. D.; Slawecki, R. A.; Carlson, G. R. RH 5849, a nonsteroidal ecdysone agonist: effects on larval Lepidoptera. Science 1988, 241, 470-472.
31. Martinez., A.; Sparks, C.; Hart, C. A.; Thompson, J.; Jepson, I. Ecdysone agonist inducible transcription in transgenic tobacco plants. Plant J. 1999, 19, 97-106.
32. Carlson, G. R.; Cress, D. E.; Dhadialla, T. S.; Hormann, R. F.; Le, D. P. Nonsteroid ligands for modulating the expression of exogenous genes via an ecdysone receptor complex; Eur. Pat. Appl. EP 99- 304444, 1999.
33. Sláma, K.; Lafont, R. Insect hormones - ecdysteroids: their presence and actions in vertebrates. Eur. J. Entomol. 1995, 92, 355-377.
34. Ecdysone: From chemistry to mode of action: Koolman, J., Ed.; Thieme: Stuttgart. 1989.
35. Dinan, L. Ecdysteroid structure and hormonal activity. In Ecdysone: from chemistry to mode of action; Koolman, J., Ed.; Thieme Verlag: Stuttgart. 1989: pp 345-354.
36. Hopfinger, A. J.; Wang, S.; Tokarski, J. S.; Jin, B.; Albuquerque, M.; Madhav, P. J.; Duraiswami, C. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Client. Soc. 1997, 119, 10509-10524.
37. Hopfinger, A.; Tokarski, J. 3D-QSAR analysis. In Practical Application of Computer- Aided Drug Design; Charifson, P. S., Ed.; Dekker: New York, 1997: p 105.
38. Hopfinger, A. J.; Duca, J. S. Extraction of pharmacophore information from high-throughput screens. Curr. Opin. Biotech. 2001, 11, 97- 103
39. Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. Comparative molecular-field analysis (CoMFA), 1. Effect of shape on binding of steroids to currier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
40. Cramer, R. D., III.; Depriest, S.; Patterson, D.; and Hecht, P. The developing practice of comparative molecular field analysis. In 3D QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 443-485.
41. 3D QSAR in Drug Design: Recent Advances; Kubinyi, H., Folkers, G., Martin, Y. C., Eds.; Kluwer/ESCOM: Dordrecht, 1998.
42. Clément, C. Y.; Bradbrook, D. A.; Lafont, R.; Dinan, L. Assessment of a microplate-based bioassay for the detection of ecdysteroid-like or antiecdysteroid activities. Insect Biochem. Mol. Biol. 1993, 23, 187- 193.
43. Moriguchi, I.; Hirono, S.; Liu, Q.; Nakagome, I.; Matsushita, Y. Simple method of calculating octanol water partition coefficient. Chem. Pharm. Bull. 1992, 40, 127-130. MlogP implemented in SYBYL programming language by Blake, J. Pfizer Inc.: Version 1.2, Nov 8, 1994.
44. Sybyl 6.5; Tripos Associates: 1699 South Hanley Road, St. Louis, MO 63144.
45. 25 stachysterone C 21 (added missing H on 0-20), shidasterone 24 (added missing H on 0-20). and 2-deoxy-20-hydroxyecdysone 22-benzoate 55 (correction of inverted configuration at C-22 and removal of superfluous keto group at C-12).
46. Huber, R.; Hoppe, W. Zur Chemie des Ecdysons, VII: Die Kristallund Molekülstrukturanalyse des Insektenverpuppungshormons Ecdyson mit der automatisierten Faltmolekülmethode, Chem. Ber. 1965, 98, 2403-2424.
47. HyperChem Program Release 5.01 for Windows; Hypercube, Inc.: 1996.
48. MOLSIM User's Guide V3.0: D. C. Doherty and The Chem21 Group, Inc.; 1780 Wilson Drive, Lake Forest, IL. 1998.
49. Tokarski, J. S.; Hopfinger, A. J. Constructing protein models for ligand-receptor binding thermodynamic simulations: an application to a set of peptidomimetic renin inhibitors. J. Chem. Inf. Comput. Sci. 1997, 17, 779-791.
50. Albuquerque, M. G.; Hopfinger, A. J.; Barreiro, E. J.; de Alencastro, R. B. Four-dimensional quantitative structure-activity relationship analysis of a series of interphenylene 7-oxobicycloheptane oxazole thromboxane A(2) receptor antagonists. J. Chem. Inf. Computer Sci. 1998, 38, 925-938.
51. Glen, W. G.; Dunn, W. J., III.; Scott, D. R. Linear regression and the partial least-squares, PLS, regression method. Tetrahedron Comput, Methods 1989, 2, 349-354.
52. 4D-QSAR Analysis User's Guide, V2.0: The Chem21 Group, Inc.: 1780 Wilson Drive. Lake Forest, IL. 2000.
53. Holland, J. Adaptation in artificial and natural Systems: University of Michigan Press: Ann Arbor, MI. 1975.
54. Rogers, D.; Hopfinger, A. J. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J. Chem. Inf. Computer. Sci. 1994, 34, 854-866.
55. Tokarski, J. S.; Hopfinger, A. J. Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidomimetic renin inhibitors. J. Chem. Inf. Comput. Sci. 1997, 37, 792-811.
56. Walters, W. P.; Stahl, M. T.; Murcko, M. A. Virtual screening - an overview, Drug Discovery Today 1998, 3, 160-194.
57. Hopfinger, A. J.; Reuka, A.; Venkatarangan, P.; Duca, J. S.; Wang, S. Construction of a virtual high throughput screen by 4D-QSAR analysis: application to a combinatorial library of glucose inhibitors of glycogen phosphorylase b. J. Chem. Inf. Comput. Sci. 1999, 39, 1151-1160.
58. Shiau, A. K.; Barstad, D.; Loria, P. M.; Cheng, L.; Kushner, P. J.; Agard, D. A.; Greene, G. L. The structural basis of estrogen receptor/ coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95, 927-937.
59. Klebe, G. Comparative molecular similarity indices analysis; COMSIA. In 3D QSAR in Drug Design; Recent Advances; Kubinyi, H., Folkers, G., Martin, Y. C., Eds.: Kluwer/ESCOM: Dordrecht, 1998; pp 87-104.
60. Wurtz, J.-M.; Guillot, B.; Fagart, J.; Moras, D.; Tietjen, K.; Schindler, M. A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: a homology modeling and docking approach. Protein Sci. 2000, 9, 1073-1084.
61. Wurtz, J.-M.; personal communication.
62. Renaud, J. P.; Rochel, N.; Ruff, M.; Vivat, V.; Chumbon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the RAR-γ ligand- binding domain board to all-trans retinoic acid. Nature 1995, 378, 681-689.
63. Rochel, N.; Wurtz, J.-M.; Mitschler, A.; Klaholz, B.; Moras, D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Molecular Cell 2000. 5, 173-179.